Journal of Neurology

, Volume 257, Issue 1, pp 114–121 | Cite as

Quantitative proton magnetic resonance spectroscopy detects abnormalities in dorsolateral prefrontal cortex and motor cortex of patients with frontotemporal lobar degeneration

  • Sanjeev Chawla
  • Sumei Wang
  • Peachie Moore
  • John H. Woo
  • Lauren Elman
  • Leo F. McCluskey
  • Elias R. Melhem
  • Murray Grossman
  • Harish Poptani
Original Communication
First Online:
Received:
Accepted:

Abstract

Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease of the frontal and temporal neocortex. The single most common pathology underlying FTLD is neuronal degeneration with ubiquitin-positive but tau-negative inclusions consisting of Tar DNA binding proteins (TDP-43). Inclusions containing TDP-43 in neurons are also the most common pathology underlying motor neuron disease (MND). The present study tested the hypothesis that abnormal metabolite patterns within the dorsolateral prefrontal cortex (DLPFC) as well as the motor cortex (MC) may be observed in FTLD patients without motor disorders, using proton magnetic resonance spectroscopy (1H MRS). Twenty-six FTLD patients with cognitive damage and ten controls underwent multivoxel 1H MRS. Absolute concentrations of N-acetyl aspartate (NAA), creatine (Cr), choline (Cho) and myo-inositol (mI) were measured from the DLPFC, the MC and the parietal cortex (PC, an internal control). Statistical analyses were performed for group differences between FTLD patients and controls. Comparisons were also made across brain regions (PC and DLPFC; PC and MC) within FTLD patients. Significant reductions in NAA and Cr along with increased Cho and mI were observed in the DLPFC of FTLD patients compared to controls. Significantly lower NAA and higher Cho were also observed in the MCs of patients as compared to controls. Within the FTLD patients, both the MC and the DLPFC exhibited significantly decreased NAA and elevated Cho compared to the PC. However, only the DLPFC had significantly lower Cr and higher mI. Abnormal metabolite pattern from the MC supports the hypothesis that FTLD and MND may be closely linked.

Keywords

Frontotemporal lobar degeneration Motor neuron disease Proton magnetic resonance spectroscopy Dorsolateral prefrontal cortex Motor cortex 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

The support of MRI coordinator Alea Khan and technologists Doris Cain, Tonya Kurtz and Patricia O’ Donnell is gratefully acknowledged. This work was funded by NIH grants AG17586, NS44266 and AG15116.

References

  1. 1.
    Bigio EH, Lipton AM, White CL 3rd, Dickson DW, Hirano A (2003) Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 29:239–253. doi: 10.1046/j.1365-2990.2003.00466.x CrossRefPubMedGoogle Scholar
  2. 2.
    Blumenfeld RS, Ranganath C (2006) Dorsolateral prefrontal cortex promotes long-term memory formation through its role in working memory organization. J Neurosci 26:916–925. doi: 10.1523/JNEUROSCI.2353-05.2006 CrossRefPubMedGoogle Scholar
  3. 3.
    Bowen BC, Pattany PM, Bradley WG, Murdoch JB, Rotta F, Younis AA, Duncan RC, Quencer RM (2000) MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. Am J Neuroradiol 21:647–658PubMedGoogle Scholar
  4. 4.
    Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289–298. doi: 10.1159/000111347 CrossRefPubMedGoogle Scholar
  5. 5.
    Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP (1999) Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 212:763–769PubMedGoogle Scholar
  6. 6.
    Chang L, Cornford M, Miller BL, Itabashi H, Mena I (1995) Neuronal ultrastructural abnormalities in a patient with frontotemporal dementia and motor neuron disease. Dementia 6:1–8. doi: 10.1159/000106915 PubMedGoogle Scholar
  7. 7.
    Cordery RJ, MacManus D, Godbolt A, Rossor MN, Waldman AD (2006) Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. Eur Radiol 16:1692–1698. doi: 10.1007/s00330-005-0090-4 CrossRefPubMedGoogle Scholar
  8. 8.
    Coulthard E, Firbank M, English P, Welch J, Birchall D, O’Brien J, Griffiths TD (2006) Proton magnetic resonance spectroscopy in frontotemporal dementia. J Neurol 253:861–868. doi: 10.1007/s00415-006-0045-y CrossRefPubMedGoogle Scholar
  9. 9.
    Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314PubMedGoogle Scholar
  10. 10.
    Ebel A, Soher BJ, Maudsley AA (2001) Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis. Magn Reson Med 46:1072–1078. doi: 10.1002/mrm.1301 CrossRefPubMedGoogle Scholar
  11. 11.
    Ernst T, Chang L, Melchor R, Mehringer CM (1997) Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203:829–836PubMedGoogle Scholar
  12. 12.
    Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, Van Deerlin V, Lee VM, Miller BL, Trojanowski JQ, Grossman M (2006) Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59:952–962. doi: 10.1002/ana.20873 CrossRefPubMedGoogle Scholar
  13. 13.
    Gerloff C, Corwell B, Chen R, Hallett M, Cohen LG (1998) The role of the human motor cortex in the control of complex and simple finger movement sequences. Brain 121:1695–1709. doi: 10.1093/brain/121.9.1695 CrossRefPubMedGoogle Scholar
  14. 14.
    Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL (1999) Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2:861–863. doi: 10.1038/13158 CrossRefPubMedGoogle Scholar
  15. 15.
    Griffith HR, den Hollander JA, Okonkwo OC, O’Brien T, Watts RL, Marson DC (2008) Brain metabolism differs in Alzheimer’s disease and Parkinson’s disease dementia. Alzheimers Dement 4:421–427. doi: 10.1016/j.jalz.2008.04.008 CrossRefPubMedGoogle Scholar
  16. 16.
    Grosskreutz J, Kaufmann J, Frädrich J, Dengler R, Heinze HJ, Peschel T (2006) Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol 25:6–17Google Scholar
  17. 17.
    Grossman M (2002) Frontotemporal dementia: a review. J Int Neuropsychol Soc 8:566–583. doi: 10.1017/S1355617702814357 CrossRefPubMedGoogle Scholar
  18. 18.
    Grossman M, Libon DJ, Forman MS, Massimo L, Wood E, Moore P, Anderson C, Farmer J, Chatterjee A, Clark CM, Coslett HB, Hurtig HI, Lee VM, Trojanowski JQ (2007) Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch Neurol 64:1601–1609. doi: 10.1001/archneur.64.11.1601 CrossRefPubMedGoogle Scholar
  19. 19.
    Grossman M, Xie SX, Libon DJ, Wang X, Massimo L, Moore P, Vesely L, Berkowitz R, Chatterjee A, Coslett HB, Hurtig HI, Forman MS, Lee VM, Trojanowski JQ (2008) Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology 70:2036–2045. doi: 10.1212/01.wnl.0000303816.25065.bc CrossRefPubMedGoogle Scholar
  20. 20.
    Guedj E, Le Ber I, Lacomblez L, Dubois B, Verpillat P, Didic M, Salachas F, Vera P, Hannequin D, Lotterie JA, Puel M, Decousus M, Thomas-Antérion C, Magne C, Vercelletto M, Bernard AM, Golfier V, Pasquier J, Michel BF, Namer I, Sellal F, Bochet J, Volteau M, Brice A, Meininger V, French RESEARCH NETWORK on FTD/FTD-MND, Habert MO (2007) Brain SPECT perfusion of frontotemporal dementia associated with motor neuron disease. Neurology 69:488–490. doi: 10.1212/01.wnl.0000266638.53185.e7 CrossRefPubMedGoogle Scholar
  21. 21.
    Hodges JR, Miller B (2001) The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: part I. Neurocase 7:31–35. doi: 10.1093/neucas/7.1.31 CrossRefPubMedGoogle Scholar
  22. 22.
    Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, Daube JR, Nance M, Fan C, Kaplan J, Hung WY, McKenna-Yasek D, Haines JL, Pericak-Vance MA, Horvitz HR, Brown RH Jr (2000) Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21–q22. JAMA 284:1664–1669. doi: 10.1001/jama.284.13.1664 CrossRefPubMedGoogle Scholar
  23. 23.
    Imre S (2004) Disorders of executive consciousness. Ideggyogy Sz 57:292–300PubMedGoogle Scholar
  24. 24.
    Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamura T, Shimomura T, Hirono N, Mori E (1998) Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 39:1875–1878PubMedGoogle Scholar
  25. 25.
    Jackson M, Lowe J (1996) The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 91:127–134. doi: 10.1007/s004010050403 CrossRefPubMedGoogle Scholar
  26. 26.
    Jagust WJ, Reed BR, Seab JP, Kramer JH, Budinger TF (1989) Clinical-physiologic correlates of Alzheimer’s disease and frontal lobe dementia. Am J Physiol Imaging 4:89–96PubMedGoogle Scholar
  27. 27.
    Josephs KA, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW (2006) Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch Neurol 63:506–512. doi: 10.1001/archneur.63.4.506 CrossRefPubMedGoogle Scholar
  28. 28.
    Kertesz A, Davidson W, Fox H (1997) Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 24:29–36PubMedGoogle Scholar
  29. 29.
    Kizu O, Yamada K, Ito H, Nishimura T (2004) Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy. Neuroradiology 46:277–281. doi: 10.1007/s00234-004-1167-5 CrossRefPubMedGoogle Scholar
  30. 30.
    Klein J (2000) Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 107:1027–1063. doi: 10.1007/s007020070051 CrossRefPubMedGoogle Scholar
  31. 31.
    Libon DJ, Massimo L, Moore P, Coslett HB, Chatterjee A, Aguirre GK, Rice A, Vesely L, Grossman M (2007) Screening for frontotemporal dementias and Alzheimer’s disease with the Philadelphia brief assessment of cognition: a preliminary analysis. Dement Geriatr Cogn Disord 24:441–447. doi: 10.1159/000110577 CrossRefPubMedGoogle Scholar
  32. 32.
    Lomen-Hoerth C, Anderson T, Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59:1077–1079CrossRefPubMedGoogle Scholar
  33. 33.
    Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60:1094–1097PubMedGoogle Scholar
  34. 34.
    Lomen-Hoerth C (2004) Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord 17:337–341. doi: 10.1159/000077167 CrossRefPubMedGoogle Scholar
  35. 35.
    Mann DM (1998) Dementia of frontal type and dementias with subcortical gliosis. Brain Pathol 8:325–338PubMedCrossRefGoogle Scholar
  36. 36.
    McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Work Group on Frontotemporal Dementia and Pick’s Disease. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol 58:1803–1809. doi: 10.1001/archneur.58.11.1803 CrossRefPubMedGoogle Scholar
  37. 37.
    Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554PubMedGoogle Scholar
  38. 38.
    Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133. doi: 10.1126/science.1134108 CrossRefPubMedGoogle Scholar
  39. 39.
    Ogar JM, Dronkers NF, Brambati SM, Miller BL, Gorno-Tempini ML (2007) Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis Assoc Disord 21:S23–S30CrossRefPubMedGoogle Scholar
  40. 40.
    Osorio JA, Ozturk-Isik E, Xu D, Cha S, Chang S, Berger MS, Vigneron DB, Nelson SJ (2007) 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil. J Magn Reson Imaging 26:23–30. doi: 10.1002/jmri.20970 CrossRefPubMedGoogle Scholar
  41. 41.
    Peters F, Perani D, Herholz K, Holthoff V, Beuthien-Baumann B, Sorbi S, Pupi A, Degueldre C, Lemaire C, Collette F, Salmon E (2006) Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord 21:373–379. doi: 10.1159/000091898 CrossRefPubMedGoogle Scholar
  42. 42.
    Petrides M, Pandya DN (1999) Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. Eur J Neurosci 11:1011–1036. doi: 10.1046/j.1460-9568.1999.00518.x CrossRefPubMedGoogle Scholar
  43. 43.
    Pohl C, Block W, Träber F, Schmidt S, Pels H, Grothe C, Schild HH, Klockgether T (2001) Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci 190:21–27. doi: 10.1016/S0022-510X(01)00568-8 CrossRefPubMedGoogle Scholar
  44. 44.
    Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679. doi: 10.1002/mrm.1910300604 CrossRefPubMedGoogle Scholar
  45. 45.
    Provencher SW (2001) Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14:260–264. doi: 10.1002/nbm.698 CrossRefPubMedGoogle Scholar
  46. 46.
    Rigotti DJ, Inglese M, Gonen O (2007) Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. Am J Neuroradiol 28:1843–1849. doi: 10.3174/ajnr.A0774 CrossRefPubMedGoogle Scholar
  47. 47.
    Sarac H, Zagar M, Vranjes D, Henigsberg N, Bilić E, Pavlisa G (2008) Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia. Coll Antropol 32(Suppl 1):205–210PubMedGoogle Scholar
  48. 48.
    Schofield E, Kersaitis C, Shepherd CE, Kril JJ, Halliday GM (2003) Severity of gliosis in Pick’s disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders. Brain 126:827–840. doi: 10.1093/brain/awg085 CrossRefPubMedGoogle Scholar
  49. 49.
    Sowell ER, Thompson PM, Holmes CJ, Jernigan TL, Toga AW (1999) In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci 2:859–861. doi: 10.1038/13154 CrossRefPubMedGoogle Scholar
  50. 50.
    Wang S, Poptani H, Woo JH, Desiderio LM, Elman LB, McCluskey LF, Krejza J, Melhem ER (2006) Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 239:831–838. doi: 10.1148/radiol.2393050573 CrossRefPubMedGoogle Scholar
  51. 51.
    Watanabe T, Shiino A, Akiguchi I (2008) Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer’s disease from Binswanger’s disease. Dement Geriatr Cogn Disord 26:89–100. doi: 10.1159/000144044 CrossRefPubMedGoogle Scholar
  52. 52.
    Whitwell JL, Josephs KA, Rossor MN, Stevens JM, Revesz T, Holton JL, Al-Sarraj S, Godbolt AK, Fox NC, Warren JD (2005) Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol 62:1402–1408. doi: 10.1001/archneur.62.9.1402 CrossRefPubMedGoogle Scholar
  53. 53.
    Xuan X, Ding M, Gong X (2008) Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies. J Neuroimaging 18:137–141CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Sanjeev Chawla
    • 1
  • Sumei Wang
    • 1
  • Peachie Moore
    • 2
  • John H. Woo
    • 1
  • Lauren Elman
    • 2
  • Leo F. McCluskey
    • 2
  • Elias R. Melhem
    • 1
  • Murray Grossman
    • 2
  • Harish Poptani
    • 1
  1. 1.Department of RadiologyUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of NeurologyUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations